The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Transdermal Skin Patch Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2028
Synopsis
The Transdermal Skin Patch market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Transdermal Skin Patch market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Relieve Severe Pain accounting for % of the Transdermal Skin Patch global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Fentanyl Transdermal Skin Patch segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Transdermal Skin Patch include Hisamitsu Pharmaceutical, Novartis, Johnson & Johnson, Teikoku Pharma, and Mylan, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Transdermal Skin Patch market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Fentanyl Transdermal Skin Patch
Nicotine Transdermal Skin Patch
Clonidine Transdermal Skin Patch
Buprenorphine Transdermal Skin Patch
Market segment by Application can be divided into
Relieve Severe Pain
Stop Smoking Cigarettes
Treat an Overactive Bladder
Others
The key market players for global Transdermal Skin Patch market are listed below:
Hisamitsu Pharmaceutical
Novartis
Johnson & Johnson
Teikoku Pharma
Mylan
Actavis
Mundipharma
Henan Lingrui Pharmaceutical
Changzhou Siyao
Rfl Pharmaceutical
Luye Pharma Group Ltd.
Purdue Pharma L.P.
Teva Pharmaceutical Industries Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Transdermal Skin Patch product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Transdermal Skin Patch, with price, sales, revenue and global market share of Transdermal Skin Patch from 2019 to 2022.
Chapter 3, the Transdermal Skin Patch competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Transdermal Skin Patch breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Transdermal Skin Patch market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Transdermal Skin Patch.
Chapter 13, 14, and 15, to describe Transdermal Skin Patch sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
The Transdermal Skin Patch market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Transdermal Skin Patch market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Relieve Severe Pain accounting for % of the Transdermal Skin Patch global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Fentanyl Transdermal Skin Patch segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Transdermal Skin Patch include Hisamitsu Pharmaceutical, Novartis, Johnson & Johnson, Teikoku Pharma, and Mylan, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Transdermal Skin Patch market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Fentanyl Transdermal Skin Patch
Nicotine Transdermal Skin Patch
Clonidine Transdermal Skin Patch
Buprenorphine Transdermal Skin Patch
Market segment by Application can be divided into
Relieve Severe Pain
Stop Smoking Cigarettes
Treat an Overactive Bladder
Others
The key market players for global Transdermal Skin Patch market are listed below:
Hisamitsu Pharmaceutical
Novartis
Johnson & Johnson
Teikoku Pharma
Mylan
Actavis
Mundipharma
Henan Lingrui Pharmaceutical
Changzhou Siyao
Rfl Pharmaceutical
Luye Pharma Group Ltd.
Purdue Pharma L.P.
Teva Pharmaceutical Industries Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Transdermal Skin Patch product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Transdermal Skin Patch, with price, sales, revenue and global market share of Transdermal Skin Patch from 2019 to 2022.
Chapter 3, the Transdermal Skin Patch competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Transdermal Skin Patch breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Transdermal Skin Patch market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Transdermal Skin Patch.
Chapter 13, 14, and 15, to describe Transdermal Skin Patch sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Transdermal Skin Patch Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Transdermal Skin Patch Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Fentanyl Transdermal Skin Patch
1.2.3 Nicotine Transdermal Skin Patch
1.2.4 Clonidine Transdermal Skin Patch
1.2.5 Buprenorphine Transdermal Skin Patch
1.3 Market Analysis by Application
1.3.1 Overview: Global Transdermal Skin Patch Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Relieve Severe Pain
1.3.3 Stop Smoking Cigarettes
1.3.4 Treat an Overactive Bladder
1.3.5 Others
1.4 Global Transdermal Skin Patch Market Size & Forecast
1.4.1 Global Transdermal Skin Patch Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Transdermal Skin Patch Sales in Volume (2017-2028)
1.4.3 Global Transdermal Skin Patch Price (2017-2028)
1.5 Global Transdermal Skin Patch Production Capacity Analysis
1.5.1 Global Transdermal Skin Patch Total Production Capacity (2017-2028)
1.5.2 Global Transdermal Skin Patch Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Transdermal Skin Patch Market Drivers
1.6.2 Transdermal Skin Patch Market Restraints
1.6.3 Transdermal Skin Patch Trends Analysis
2 Manufacturers Profiles
2.1 Hisamitsu Pharmaceutical
2.1.1 Hisamitsu Pharmaceutical Details
2.1.2 Hisamitsu Pharmaceutical Major Business
2.1.3 Hisamitsu Pharmaceutical Transdermal Skin Patch Product and Services
2.1.4 Hisamitsu Pharmaceutical Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Transdermal Skin Patch Product and Services
2.2.4 Novartis Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Transdermal Skin Patch Product and Services
2.3.4 Johnson & Johnson Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Teikoku Pharma
2.4.1 Teikoku Pharma Details
2.4.2 Teikoku Pharma Major Business
2.4.3 Teikoku Pharma Transdermal Skin Patch Product and Services
2.4.4 Teikoku Pharma Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Mylan
2.5.1 Mylan Details
2.5.2 Mylan Major Business
2.5.3 Mylan Transdermal Skin Patch Product and Services
2.5.4 Mylan Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Actavis
2.6.1 Actavis Details
2.6.2 Actavis Major Business
2.6.3 Actavis Transdermal Skin Patch Product and Services
2.6.4 Actavis Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Mundipharma
2.7.1 Mundipharma Details
2.7.2 Mundipharma Major Business
2.7.3 Mundipharma Transdermal Skin Patch Product and Services
2.7.4 Mundipharma Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Henan Lingrui Pharmaceutical
2.8.1 Henan Lingrui Pharmaceutical Details
2.8.2 Henan Lingrui Pharmaceutical Major Business
2.8.3 Henan Lingrui Pharmaceutical Transdermal Skin Patch Product and Services
2.8.4 Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Changzhou Siyao
2.9.1 Changzhou Siyao Details
2.9.2 Changzhou Siyao Major Business
2.9.3 Changzhou Siyao Transdermal Skin Patch Product and Services
2.9.4 Changzhou Siyao Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Rfl Pharmaceutical
2.10.1 Rfl Pharmaceutical Details
2.10.2 Rfl Pharmaceutical Major Business
2.10.3 Rfl Pharmaceutical Transdermal Skin Patch Product and Services
2.10.4 Rfl Pharmaceutical Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Luye Pharma Group Ltd.
2.11.1 Luye Pharma Group Ltd. Details
2.11.2 Luye Pharma Group Ltd. Major Business
2.11.3 Luye Pharma Group Ltd. Transdermal Skin Patch Product and Services
2.11.4 Luye Pharma Group Ltd. Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Purdue Pharma L.P.
2.12.1 Purdue Pharma L.P. Details
2.12.2 Purdue Pharma L.P. Major Business
2.12.3 Purdue Pharma L.P. Transdermal Skin Patch Product and Services
2.12.4 Purdue Pharma L.P. Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Teva Pharmaceutical Industries Ltd.
2.13.1 Teva Pharmaceutical Industries Ltd. Details
2.13.2 Teva Pharmaceutical Industries Ltd. Major Business
2.13.3 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Product and Services
2.13.4 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Transdermal Skin Patch Breakdown Data by Manufacturer
3.1 Global Transdermal Skin Patch Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Transdermal Skin Patch Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Transdermal Skin Patch
3.4 Market Concentration Rate
3.4.1 Top 3 Transdermal Skin Patch Manufacturer Market Share in 2021
3.4.2 Top 6 Transdermal Skin Patch Manufacturer Market Share in 2021
3.5 Global Transdermal Skin Patch Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Transdermal Skin Patch Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Transdermal Skin Patch Market Size by Region
4.1.1 Global Transdermal Skin Patch Sales in Volume by Region (2017-2028)
4.1.2 Global Transdermal Skin Patch Revenue by Region (2017-2028)
4.2 North America Transdermal Skin Patch Revenue (2017-2028)
4.3 Europe Transdermal Skin Patch Revenue (2017-2028)
4.4 Asia-Pacific Transdermal Skin Patch Revenue (2017-2028)
4.5 South America Transdermal Skin Patch Revenue (2017-2028)
4.6 Middle East and Africa Transdermal Skin Patch Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Transdermal Skin Patch Sales in Volume by Type (2017-2028)
5.2 Global Transdermal Skin Patch Revenue by Type (2017-2028)
5.3 Global Transdermal Skin Patch Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Transdermal Skin Patch Sales in Volume by Application (2017-2028)
6.2 Global Transdermal Skin Patch Revenue by Application (2017-2028)
6.3 Global Transdermal Skin Patch Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Transdermal Skin Patch Sales by Type (2017-2028)
7.2 North America Transdermal Skin Patch Sales by Application (2017-2028)
7.3 North America Transdermal Skin Patch Market Size by Country
7.3.1 North America Transdermal Skin Patch Sales in Volume by Country (2017-2028)
7.3.2 North America Transdermal Skin Patch Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Transdermal Skin Patch Sales by Type (2017-2028)
8.2 Europe Transdermal Skin Patch Sales by Application (2017-2028)
8.3 Europe Transdermal Skin Patch Market Size by Country
8.3.1 Europe Transdermal Skin Patch Sales in Volume by Country (2017-2028)
8.3.2 Europe Transdermal Skin Patch Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Transdermal Skin Patch Sales by Type (2017-2028)
9.2 Asia-Pacific Transdermal Skin Patch Sales by Application (2017-2028)
9.3 Asia-Pacific Transdermal Skin Patch Market Size by Region
9.3.1 Asia-Pacific Transdermal Skin Patch Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Transdermal Skin Patch Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Transdermal Skin Patch Sales by Type (2017-2028)
10.2 South America Transdermal Skin Patch Sales by Application (2017-2028)
10.3 South America Transdermal Skin Patch Market Size by Country
10.3.1 South America Transdermal Skin Patch Sales in Volume by Country (2017-2028)
10.3.2 South America Transdermal Skin Patch Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Transdermal Skin Patch Sales by Type (2017-2028)
11.2 Middle East & Africa Transdermal Skin Patch Sales by Application (2017-2028)
11.3 Middle East & Africa Transdermal Skin Patch Market Size by Country
11.3.1 Middle East & Africa Transdermal Skin Patch Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Transdermal Skin Patch Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Transdermal Skin Patch and Key Manufacturers
12.2 Manufacturing Costs Percentage of Transdermal Skin Patch
12.3 Transdermal Skin Patch Production Process
12.4 Transdermal Skin Patch Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Transdermal Skin Patch Typical Distributors
13.3 Transdermal Skin Patch Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of TablesList of Tables
Table 1. Global Transdermal Skin Patch Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Transdermal Skin Patch Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Hisamitsu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Hisamitsu Pharmaceutical Major Business
Table 5. Hisamitsu Pharmaceutical Transdermal Skin Patch Product and Services
Table 6. Hisamitsu Pharmaceutical Transdermal Skin Patch Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Major Business
Table 9. Novartis Transdermal Skin Patch Product and Services
Table 10. Novartis Transdermal Skin Patch Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 12. Johnson & Johnson Major Business
Table 13. Johnson & Johnson Transdermal Skin Patch Product and Services
Table 14. Johnson & Johnson Transdermal Skin Patch Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Teikoku Pharma Basic Information, Manufacturing Base and Competitors
Table 16. Teikoku Pharma Major Business
Table 17. Teikoku Pharma Transdermal Skin Patch Product and Services
Table 18. Teikoku Pharma Transdermal Skin Patch Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Mylan Basic Information, Manufacturing Base and Competitors
Table 20. Mylan Major Business
Table 21. Mylan Transdermal Skin Patch Product and Services
Table 22. Mylan Transdermal Skin Patch Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Actavis Basic Information, Manufacturing Base and Competitors
Table 24. Actavis Major Business
Table 25. Actavis Transdermal Skin Patch Product and Services
Table 26. Actavis Transdermal Skin Patch Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Mundipharma Basic Information, Manufacturing Base and Competitors
Table 28. Mundipharma Major Business
Table 29. Mundipharma Transdermal Skin Patch Product and Services
Table 30. Mundipharma Transdermal Skin Patch Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Henan Lingrui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 32. Henan Lingrui Pharmaceutical Major Business
Table 33. Henan Lingrui Pharmaceutical Transdermal Skin Patch Product and Services
Table 34. Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Changzhou Siyao Basic Information, Manufacturing Base and Competitors
Table 36. Changzhou Siyao Major Business
Table 37. Changzhou Siyao Transdermal Skin Patch Product and Services
Table 38. Changzhou Siyao Transdermal Skin Patch Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Rfl Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 40. Rfl Pharmaceutical Major Business
Table 41. Rfl Pharmaceutical Transdermal Skin Patch Product and Services
Table 42. Rfl Pharmaceutical Transdermal Skin Patch Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Luye Pharma Group Ltd. Basic Information, Manufacturing Base and Competitors
Table 44. Luye Pharma Group Ltd. Major Business
Table 45. Luye Pharma Group Ltd. Transdermal Skin Patch Product and Services
Table 46. Luye Pharma Group Ltd. Transdermal Skin Patch Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Purdue Pharma L.P. Basic Information, Manufacturing Base and Competitors
Table 48. Purdue Pharma L.P. Major Business
Table 49. Purdue Pharma L.P. Transdermal Skin Patch Product and Services
Table 50. Purdue Pharma L.P. Transdermal Skin Patch Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 52. Teva Pharmaceutical Industries Ltd. Major Business
Table 53. Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Product and Services
Table 54. Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Global Transdermal Skin Patch Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 56. Global Transdermal Skin Patch Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 57. Market Position of Manufacturers in Transdermal Skin Patch, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 58. Global Transdermal Skin Patch Production Capacity by Company, (K Units): 2020 VS 2021
Table 59. Head Office and Transdermal Skin Patch Production Site of Key Manufacturer
Table 60. Transdermal Skin Patch New Entrant and Capacity Expansion Plans
Table 61. Transdermal Skin Patch Mergers & Acquisitions in the Past Five Years
Table 62. Global Transdermal Skin Patch Sales by Region (2017-2022) & (K Units)
Table 63. Global Transdermal Skin Patch Sales by Region (2023-2028) & (K Units)
Table 64. Global Transdermal Skin Patch Revenue by Region (2017-2022) & (USD Million)
Table 65. Global Transdermal Skin Patch Revenue by Region (2023-2028) & (USD Million)
Table 66. Global Transdermal Skin Patch Sales by Type (2017-2022) & (K Units)
Table 67. Global Transdermal Skin Patch Sales by Type (2023-2028) & (K Units)
Table 68. Global Transdermal Skin Patch Revenue by Type (2017-2022) & (USD Million)
Table 69. Global Transdermal Skin Patch Revenue by Type (2023-2028) & (USD Million)
Table 70. Global Transdermal Skin Patch Price by Type (2017-2022) & (USD/Unit)
Table 71. Global Transdermal Skin Patch Price by Type (2023-2028) & (USD/Unit)
Table 72. Global Transdermal Skin Patch Sales by Application (2017-2022) & (K Units)
Table 73. Global Transdermal Skin Patch Sales by Application (2023-2028) & (K Units)
Table 74. Global Transdermal Skin Patch Revenue by Application (2017-2022) & (USD Million)
Table 75. Global Transdermal Skin Patch Revenue by Application (2023-2028) & (USD Million)
Table 76. Global Transdermal Skin Patch Price by Application (2017-2022) & (USD/Unit)
Table 77. Global Transdermal Skin Patch Price by Application (2023-2028) & (USD/Unit)
Table 78. North America Transdermal Skin Patch Sales by Country (2017-2022) & (K Units)
Table 79. North America Transdermal Skin Patch Sales by Country (2023-2028) & (K Units)
Table 80. North America Transdermal Skin Patch Revenue by Country (2017-2022) & (USD Million)
Table 81. North America Transdermal Skin Patch Revenue by Country (2023-2028) & (USD Million)
Table 82. North America Transdermal Skin Patch Sales by Type (2017-2022) & (K Units)
Table 83. North America Transdermal Skin Patch Sales by Type (2023-2028) & (K Units)
Table 84. North America Transdermal Skin Patch Sales by Application (2017-2022) & (K Units)
Table 85. North America Transdermal Skin Patch Sales by Application (2023-2028) & (K Units)
Table 86. Europe Transdermal Skin Patch Sales by Country (2017-2022) & (K Units)
Table 87. Europe Transdermal Skin Patch Sales by Country (2023-2028) & (K Units)
Table 88. Europe Transdermal Skin Patch Revenue by Country (2017-2022) & (USD Million)
Table 89. Europe Transdermal Skin Patch Revenue by Country (2023-2028) & (USD Million)
Table 90. Europe Transdermal Skin Patch Sales by Type (2017-2022) & (K Units)
Table 91. Europe Transdermal Skin Patch Sales by Type (2023-2028) & (K Units)
Table 92. Europe Transdermal Skin Patch Sales by Application (2017-2022) & (K Units)
Table 93. Europe Transdermal Skin Patch Sales by Application (2023-2028) & (K Units)
Table 94. Asia-Pacific Transdermal Skin Patch Sales by Region (2017-2022) & (K Units)
Table 95. Asia-Pacific Transdermal Skin Patch Sales by Region (2023-2028) & (K Units)
Table 96. Asia-Pacific Transdermal Skin Patch Revenue by Region (2017-2022) & (USD Million)
Table 97. Asia-Pacific Transdermal Skin Patch Revenue by Region (2023-2028) & (USD Million)
Table 98. Asia-Pacific Transdermal Skin Patch Sales by Type (2017-2022) & (K Units)
Table 99. Asia-Pacific Transdermal Skin Patch Sales by Type (2023-2028) & (K Units)
Table 100. Asia-Pacific Transdermal Skin Patch Sales by Application (2017-2022) & (K Units)
Table 101. Asia-Pacific Transdermal Skin Patch Sales by Application (2023-2028) & (K Units)
Table 102. South America Transdermal Skin Patch Sales by Country (2017-2022) & (K Units)
Table 103. South America Transdermal Skin Patch Sales by Country (2023-2028) & (K Units)
Table 104. South America Transdermal Skin Patch Revenue by Country (2017-2022) & (USD Million)
Table 105. South America Transdermal Skin Patch Revenue by Country (2023-2028) & (USD Million)
Table 106. South America Transdermal Skin Patch Sales by Type (2017-2022) & (K Units)
Table 107. South America Transdermal Skin Patch Sales by Type (2023-2028) & (K Units)
Table 108. South America Transdermal Skin Patch Sales by Application (2017-2022) & (K Units)
Table 109. South America Transdermal Skin Patch Sales by Application (2023-2028) & (K Units)
Table 110. Middle East & Africa Transdermal Skin Patch Sales by Region (2017-2022) & (K Units)
Table 111. Middle East & Africa Transdermal Skin Patch Sales by Region (2023-2028) & (K Units)
Table 112. Middle East & Africa Transdermal Skin Patch Revenue by Region (2017-2022) & (USD Million)
Table 113. Middle East & Africa Transdermal Skin Patch Revenue by Region (2023-2028) & (USD Million)
Table 114. Middle East & Africa Transdermal Skin Patch Sales by Type (2017-2022) & (K Units)
Table 115. Middle East & Africa Transdermal Skin Patch Sales by Type (2023-2028) & (K Units)
Table 116. Middle East & Africa Transdermal Skin Patch Sales by Application (2017-2022) & (K Units)
Table 117. Middle East & Africa Transdermal Skin Patch Sales by Application (2023-2028) & (K Units)
Table 118. Transdermal Skin Patch Raw Material
Table 119. Key Manufacturers of Transdermal Skin Patch Raw Materials
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Transdermal Skin Patch Typical Distributors
Table 123. Transdermal Skin Patch Typical Customers
List of Figures
Figure 1. Transdermal Skin Patch Picture
Figure 2. Global Transdermal Skin Patch Revenue Market Share by Type in 2021
Figure 3. Fentanyl Transdermal Skin Patch
Figure 4. Nicotine Transdermal Skin Patch
Figure 5. Clonidine Transdermal Skin Patch
Figure 6. Buprenorphine Transdermal Skin Patch
Figure 7. Global Transdermal Skin Patch Revenue Market Share by Application in 2021
Figure 8. Relieve Severe Pain
Figure 9. Stop Smoking Cigarettes
Figure 10. Treat an Overactive Bladder
Figure 11. Others
Figure 12. Global Transdermal Skin Patch Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global Transdermal Skin Patch Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Transdermal Skin Patch Sales (2017-2028) & (K Units)
Figure 15. Global Transdermal Skin Patch Price (2017-2028) & (USD/Unit)
Figure 16. Global Transdermal Skin Patch Production Capacity (2017-2028) & (K Units)
Figure 17. Global Transdermal Skin Patch Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Transdermal Skin Patch Market Drivers
Figure 19. Transdermal Skin Patch Market Restraints
Figure 20. Transdermal Skin Patch Market Trends
Figure 21. Global Transdermal Skin Patch Sales Market Share by Manufacturer in 2021
Figure 22. Global Transdermal Skin Patch Revenue Market Share by Manufacturer in 2021
Figure 23. Transdermal Skin Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Transdermal Skin Patch Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Transdermal Skin Patch Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Transdermal Skin Patch Sales Market Share by Region (2017-2028)
Figure 27. Global Transdermal Skin Patch Revenue Market Share by Region (2017-2028)
Figure 28. North America Transdermal Skin Patch Revenue (2017-2028) & (USD Million)
Figure 29. Europe Transdermal Skin Patch Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Transdermal Skin Patch Revenue (2017-2028) & (USD Million)
Figure 31. South America Transdermal Skin Patch Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Transdermal Skin Patch Revenue (2017-2028) & (USD Million)
Figure 33. Global Transdermal Skin Patch Sales Market Share by Type (2017-2028)
Figure 34. Global Transdermal Skin Patch Revenue Market Share by Type (2017-2028)
Figure 35. Global Transdermal Skin Patch Price by Type (2017-2028) & (USD/Unit)
Figure 36. Global Transdermal Skin Patch Sales Market Share by Application (2017-2028)
Figure 37. Global Transdermal Skin Patch Revenue Market Share by Application (2017-2028)
Figure 38. Global Transdermal Skin Patch Price by Application (2017-2028) & (USD/Unit)
Figure 39. North America Transdermal Skin Patch Sales Market Share by Type (2017-2028)
Figure 40. North America Transdermal Skin Patch Sales Market Share by Application (2017-2028)
Figure 41. North America Transdermal Skin Patch Sales Market Share by Country (2017-2028)
Figure 42. North America Transdermal Skin Patch Revenue Market Share by Country (2017-2028)
Figure 43. United States Transdermal Skin Patch Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Transdermal Skin Patch Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Transdermal Skin Patch Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Transdermal Skin Patch Sales Market Share by Type (2017-2028)
Figure 47. Europe Transdermal Skin Patch Sales Market Share by Application (2017-2028)
Figure 48. Europe Transdermal Skin Patch Sales Market Share by Country (2017-2028)
Figure 49. Europe Transdermal Skin Patch Revenue Market Share by Country (2017-2028)
Figure 50. Germany Transdermal Skin Patch Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Transdermal Skin Patch Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Transdermal Skin Patch Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Transdermal Skin Patch Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Transdermal Skin Patch Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Transdermal Skin Patch Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Transdermal Skin Patch Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Transdermal Skin Patch Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Transdermal Skin Patch Revenue Market Share by Region (2017-2028)
Figure 59. China Transdermal Skin Patch Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Transdermal Skin Patch Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Transdermal Skin Patch Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Transdermal Skin Patch Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Transdermal Skin Patch Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Transdermal Skin Patch Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Transdermal Skin Patch Sales Market Share by Type (2017-2028)
Figure 66. South America Transdermal Skin Patch Sales Market Share by Application (2017-2028)
Figure 67. South America Transdermal Skin Patch Sales Market Share by Country (2017-2028)
Figure 68. South America Transdermal Skin Patch Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Transdermal Skin Patch Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Transdermal Skin Patch Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Transdermal Skin Patch Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Transdermal Skin Patch Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Transdermal Skin Patch Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Transdermal Skin Patch Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Transdermal Skin Patch Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Transdermal Skin Patch Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Transdermal Skin Patch Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Transdermal Skin Patch Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Transdermal Skin Patch in 2021
Figure 80. Manufacturing Process Analysis of Transdermal Skin Patch
Figure 81. Transdermal Skin Patch Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
